Verdict: APPROVE

## Blockers
None. This is a documentation-only change to two process docs with no code, asset, or tool-profile impact.

## Major Issues
None. The Codex conclusion is correctly supported by the repo evidence cited: direct-read smoke artifacts are explicitly `OperatorArtifactNotGreenlight`, Blender MCP connectivity is distinct from Unreal/Niagara editor access, and no evidence of live editor/Unreal Python/asset-write grants exists. The "no" answer to the first user question is accurate and conservative.

## Minor Issues
- The packet says the active agent should "proceed without asking for extra confirmation just to apply the switch." Confirm this is reconciled with AGENTS.md's existing approval-gate language so a reader does not infer the switch bypasses any *other* required confirmation. The proposed role-restatement sentence covers this, but the docs should make clear the no-confirmation rule applies *only* to the routing switch itself.
- The registry row trigger update should preserve any existing trigger phrases rather than replace them; the packet says "include" which is correct — just ensure the edit appends rather than overwrites.

## Clarifying Questions
None blocking. The scope, command mapping, and inverse-validator rule are unambiguous.

## Required Verification
- `git diff --check -- AGENTS.md Scripts/README.md` (whitespace/conflict markers).
- `Select-String` for `Make Claude operator` and `Make Codex operator` in both edited docs, plus the role-routing-only / no-permission-widening sentence in each.
- Confirm the AGENTS.md registry row still contains its prior trigger phrases after the edit (grep the row, verify additive).
- Final answer must explicitly distinguish: confirmed (direct repo read, Blender MCP) vs. unconfirmed (Unreal/Niagara editor, Unreal Python, direct asset writes).

## Rationale
The plan is in scope, reversible, and adds explicit guardrails (role-routing-only, no permission widening, mandatory inverse-validator, evidence-distinction control) that directly counter the misuse risks it identifies. The substantive answer matches the cited evidence and stays conservative on Claude's access. Verification is proportionate for a doc-only change. No product-direction or risk-acceptance decision is required from the user, so this is safe for Codex to proceed under the reviewed scope.

